Peter Banks, M.D.
Dr. Banks is currently the Director of Hematopathology at Carolinas Medical Center in North Carolina, and has been practicing, teaching, and publishing extensively for over 30 years. He has twice been recognized by The Best Doctors in America, and twice won Teacher of the Year honors (in pathology) at the Mayo Clinic. His current academic appointment is as Adjunct Professor of Pathology at the University of North Carolina in Chapel Hill, where he continues to actively participate in resident education. He has also held leadership positions at many influential professional organizations, including the Society for Hematopathology (President 1996-1998), and the North Carolina Society of Pathologists (President-Elect).
Richard A. Bender, M.D., F.A.C.P.
Dr. Bender is the Chief Medical Officer and VP for Agendia B.V, a leader in genomic testing for cancer. Dr. Bender received his MD degree from the UCLA School of Medicine followed by specialty training in Internal Medicine at UCLA-Harbor General Hospital. He then spent the next 6 years at the National Cancer Institute receiving his subspecialty training in hematology and medical oncology and as a senior investigator in the Medicine Branch doing laboratory and clinical research. He then moved to Scripps Clinic and Research Foundation where he spent an additional 4 years dividing his time between laboratory research in folate transport and clinical practice. In 1982, he began a 2-decade career at Kaiser Permanente in San Diego, helping to develop their oncology program into one of the busiest in the western US. In addition, Dr. Bender served on the executive board of the San Diego Hospice and American Cancer Society and served as a clinical instructor at the UC, San Diego School of Medicine during this period. He was also a Senior Director in the oncology division of Johnson and Johnson, and the medical director for hematology and oncology for Quest Diagnostics, a position he held for almost 6 years. He continues to teach at the UC, Irvine School of Medicine and to co-edit Anti-Cancer Drugs, an international oncology journal, as well at to serve as an expert reviewer in oncology for the Medical Board of California. Dr. Bender is the author of over 70 peer-reviewed scientific articles and numerous book chapters on topics including malignant lymphoma, pancreatic cancer and the clinical pharmacology of Vinca alkaloids.
James Crawford, M.D., Ph.D.
Dr. Crawford is the Chair of the Pathology Department at the University of Florida College of Medicine. Prior to joining the University of Florida in 1999, Dr. Crawford was faculty at Brigham & Women’s Hospital and Harvard Medical School, and the Yale University School of Medicine. Dr. Crawford is Editor in Chief of Laboratory Investigation, President of the Association of Pathology Chairs, and Chair of the Pathology Working Group for the NCI Network for Translational Research in Optical Imaging. Dr. Crawford is also Chair of the Board of Directors for PathPAC, the political action committee of the College of American Pathologists, and is a member of the College's Council for Government and Professional Affairs. He is a member of the Association of American Medical Colleges Council of Academic Societies Administrative Board. Dr. Crawford is a world expert in hepatic pathology and pathobiology, and is author of over 170 original articles and book chapters, and Senior Editor of 3 books. He received his M.D. and Ph.D. from Duke University, did his Pathology Residency and Gastrointestinal Pathology Fellowship at Brigham & Women's Hospital, and a Fellowship in Hepatopathology at the Royal Free Hospital in London.
Kathrine Frey, M.D.
Dr. Frey is an anatomic and clinical pathologist at Fairview Southdale Hospital in Minnesota, where she is also Director of Transfusion Medicine Services. Although most of her time is devoted to anatomic pathology, Dr. Frey has also been highly involved in transfusion medicine, including serving on blood center boards and in medical advisory roles. Dr. Frey’s current interests include human factors engineering and high reliability industrial principles as applied to pathology as well as management and prevention of patient adverse events. She is an active participant on an error reduction project with the Institute for Healthcare Improvement and has recently joined the Quality and Practice Committee of the College of American Pathologists.
Eric Glassy, M.D.
Dr. Glassy, who trained as a pathologist, is currently Information Systems Director and New Media Consultant at Pathology Inc. and Laboratory Director at Little Company of Mary Hospital in San Pedro, CA. Previously, Dr. Glassy has practiced pathology and directed laboratories throughout California, while also holding adjunct faculty positions at CSU Fullerton. Dr. Glassy is a member of the Alpha Sigma Nu Honor Society and has won numerous pathology awards. He has chaired many hospital committees as well as national committees for the College of American Pathologists. He has edited, written and illustrated several medical textbooks and developed software programs such as ePathComposer, ePathBanker, ePathFish, and PathTrac, for pathology reporting, outreach, and practice management. He also holds a green belt in Six Sigma.
Jeffrey Myers, M.D.
Dr. Myers is currently the A. James French Professor of Diagnostic Pathology and Director of the Division of Anatomic Pathology at the University of Michigan School of Medicine. Prior to his position at the University of Michigan, Dr. Myers chaired the division of surgical pathology, and later the division of anatomic pathology at the Mayo Clinic, where he also served as a professor of pathology. Since 2002, Dr. Myers has been recognized by Best Doctors in America three times and once by America’s Top Doctors. Throughout his career, Dr. Myers has held leadership positions both at the national level and within his institutions, including chair of the Strategic Planning and Education Committees for the United States and Canadian Academy of Pathology.
Luke A. Perkocha, M.D., MBA
Dr. Perkocha practices pathology in a regional laboratory that serves hospitals, physicians, and patients in a large area of northwestern Nevada and northeastern California. Until recently, he was on the regular teaching faculty of the Dermatology and Pathology Departments at UC San Francisco, where he received multiple teaching awards. He is now on the faculty of Dermatology at UC Davis. He has been active in organized medicine and is recent Past-President of the American Pathology Foundation. Dr. Perkocha has served on the boards of several regional business organizations in the San Francisco Bay Area. He has a special interest in healthcare economics and policy and has also served on the business or scientific advisory boards of several technology companies.
Paul Raslavicus, M.D.
Dr. Raslavicus is the current Secretary-Treasurer of the World Association of Societies of Pathology and Laboratory Medicine and is a Clinical Professor of Pathology at the Tufts University School of Medicine. Dr. Raslavicus has been deeply involved with the activities of the CAP for over two decades. He served as the chair of its Council on Government and Professional Affairs and its Information Services Committee. Within the latter he assessed the future of pathology informatics, digital pathology imaging, and the development of a pathology DICOM standard. Dr. Raslavicus was the College President from 2001-2003, and the College honored him as Pathologist of the Year in 2004.
John Spinosa, M.D., Ph.D.
Dr. Spinosa is a partner at Laboratory Diagnostics Medical Group, a pathology group serving San Diego area hospitals. In addition to his clinical work, Dr. Spinosa has been an active leader within the hospitals he covers. He has over 10 years experience chairing pathology departments, was Medical Director at Scripps East County from 1997-2000, and is currently the Chief of Staff at Scripps Memorial Hospital in La Jolla. Dr. Spinosa also serves as the medical director at numerous San Diego area reference laboratories. Between 1994 and 2003, Dr. Spinosa served on the CAP Informatics Committee, was the CAP voting representative at HL7, and represented the CAP on the ANSI Health Information Standards Board.
Paul Urie, M.D., Ph.D.
Dr. Urie is a surgical pathologist currently working for Intermountain Health Care in Utah, where he is the Medical Director of the Pathology and Laboratory Medicwine clinical service. Dr. Urie has been practicing in Utah since the early 1980’s, during which time he has also maintained adjunct faculty positions at the University of Utah School of Medicine and at BYU, where he is in the Department of Microbiology and Molecular Biology. Since 2002, he has been a member of the Scientific Advisory Committee at Tamtron Corporation. Dr. Urie has also served as the president of the Utah Society of Pathologists and has been a delegate to the Utah State Medical Society.
